Abstract
Rhodotorulae are environmentally ubiquitous yeasts that were originally considered non-pathogenic. However, over the last fifty years, Rhodotorula mucilaginosa (R. mucilaginosa) has established itself as an emerging opportunistic pathogen incriminated in several systemic and localized infections in humans and animals. Most of the rhodotorulosis cases were linked directly or indirectly to an immunocompromising event in the affected cases. Nevertheless, recently, a few non-immunocompromised cases were reported. In the current study, performed throughout the period from April/2023 to April/2024, 450 samples were collected from pet animals and investigated for the existence and coexistence of Rhodotorula spp. in different clinically diagnosed infectious cases. 173 (38.5%) samples showed positive direct microscopic slides of different sizes of Gram-positive budding yeast cells, 21 (4.7%). Rhodotorula isolates mixed with other yeasts and/or bacterial pathogens were recovered from nasal passages and ear canal swabs collected from dogs and cats suffering from nasal affection and otitis externa. Laboratory investigations were based on sample collection, microscopic examination, primary isolation and identification, biochemical and post-culturing characterization, antifungal susceptibility testing, VITEK 2 Compact Identification System, DNA extraction, PCR amplification, sequencing, and phylogenetic analysis. Moreover, antifungal susceptibility testing based on the standard broth microdilution test was applied to the recovered Rhodotorula isolates. In conclusion, the present findings spotlighted a prospective insight into the role of the emergence of R. mucilaginosa among pet animals and its possible public health concerns. Clinical trial number: Not Applicable.